Skip to main content
Premium Trial:

Request an Annual Quote

John DelliSanti

Caliper Life Sciences has named John DelliSanti to the posts of executive vice president and COO. In the job, DelliSanti will oversee the company’s worldwide sales, marketing, and services functions.
DelliSanti previously led Invitrogen’s American commercial operations, worked in international sales and services at Accelrys for a dozen years, and worked for Wyeth Pharmaceuticals and Hitachi Instruments.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.